F
Fengmei Wang
Researcher at Tianjin Medical University
Publications - 35
Citations - 397
Fengmei Wang is an academic researcher from Tianjin Medical University. The author has contributed to research in topics: Medicine & Hepatocellular carcinoma. The author has an hindex of 9, co-authored 24 publications receiving 280 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
TL;DR: It is suggested that tumor-infiltrating FoxP3+ T cells were a factor for a poor prognosis for HCC and GC, but a good prog outlook for CRC.
Journal ArticleDOI
Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.
Fang Wang,Hui Liu,Fengmei Wang,Ruicheng Xu,Peng Wang,Fei Tang,Zhang Xu,Zhengyan Zhu,Hongmin Lv,Tao Han +9 more
TL;DR: It was demonstrated that propranolol inhibited proliferation, promoted apoptosis and induced S-phase arrest in HepG 2 and HepG2.2.15 cell lines, while HL-7702 cells were arrested at the G0/G1 phase of the cell cycle.
Journal ArticleDOI
Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
Fengmei Wang,Xiang Jing,Ge Li,Tao Wang,Bin Yang,Zhu Zhengyan,Yingtang Gao,Qin Zhang,Yankai Yang,Yijun Wang,Peng Wang,Zhi Du +11 more
TL;DR: Recent studies have focused on regulatory T cells (Tregs) in chronic hepatitis B and hepatocellular carcinoma and they were also conducted independently of each other.
Journal ArticleDOI
Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.
TL;DR: Evidence is provided that the HFE C282Y and H63D polymorphisms confer increased genetic susceptibility to NAFLD and HCC but not liver cirrhosis, which is supported by a meta-analysis.
Journal ArticleDOI
Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma
TL;DR: Investigating the changes of circulating T-cell subsets after microwave ablation found that circulating Th17 cells is indeed a related factor of tumor recurrence and may evoke a transitional immune response by increasing the frequency of Th 17 cells.